Prostatic adenocarcinoma CNS parenchymal and dural metastases: alterations in ERG, CHD1 and MAP3K7 expression

[1]  M. Loda,et al.  Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate , 2018, Molecular Cancer Research.

[2]  H. Scher,et al.  Clinical implications of PTEN loss in prostate cancer , 2018, Nature Reviews Urology.

[3]  T. Bismar,et al.  ERG expression in prostate cancer: biological relevance and clinical implication , 2016, Journal of Cancer Research and Clinical Oncology.

[4]  M. Loda,et al.  Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancer. , 2015, Cancer research.

[5]  L. Bubendorf,et al.  ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer , 2014, Prostate Cancer and Prostatic Disease.

[6]  M. Rosenblum,et al.  Brain Metastases from Prostate Cancer: An 11‐Year Analysis in the MRI Era with Emphasis on Imaging Characteristics, Incidence, and Prognosis , 2014, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[7]  L. Bégin,et al.  ERG protein expression and gene rearrangements are present at lower rates in metastatic and locally advanced castration-resistant prostate cancer compared to localized disease. , 2013, Urology.

[8]  B. Czerniak,et al.  The relationship of TMPRSS2-ERG gene fusion between primary and metastatic prostate cancers. , 2012, Human pathology.

[9]  K. Lillehei,et al.  Ectopic pituitary adenoma of the clivus presenting with apoplexy: case report and review of the literature. , 2012, Clinical neuropathology.

[10]  V. Puduvalli,et al.  Brain metastasis from prostate carcinoma , 2003, Cancer.